Carbon 11-labeled Pittsburgh Compound B and carbon 11-labeled (R)-PK11195 positron emission tomographic imaging in Alzheimer disease. - Wikidata - awgldk - TriplyDB

Carbon 11-labeled Pittsburgh Compound B and carbon 11-labeled (R)-PK11195 positron emission tomographic imaging in Alzheimer disease.

Carbon 11-labeled Pittsburgh Compound B and carbon 11-labeled (R)-PK11195 positron emission tomographic imaging in Alzheimer disease.

http://www.wikidata.org/entity/Q37153379

about

Targeting innate immunity for neurodegenerative disorders of the central nervous system Neuroimaging biomarkers of neurodegenerative diseases and dementia Binding mode of Thioflavin T and other molecular probes in the context of amyloid fibrils-current status Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer's disease ³H-deprenyl and ³H-PIB autoradiography show different laminar distributions of astroglia and fibrillar β-amyloid in Alzheimer brain Synaptic plasticity in the hippocampus of a APP/PS1 mouse model of Alzheimer's disease is impaired in old but not young mice.Translocator Protein-18 kDa (TSPO) Positron Emission Tomography (PET) Imaging and Its Clinical Impact in Neurodegenerative Diseases Inflammation, microglia, and Alzheimer's disease.NOX activity is increased in mild cognitive impairment Mapping brain beta-amyloid.Tracking neuroinflammation in Alzheimer's disease: the role of positron emission tomography imaging.Lessons from Multicenter Studies on CSF Biomarkers for Alzheimer's Disease.Brain imaging in the study of Alzheimer's disease A survey of FDG- and amyloid-PET imaging in dementia and GRADE analysis Reactive glia not only associates with plaques but also parallels tangles in Alzheimer's disease Biomarkers for microglial activation in Alzheimer's disease.The classification of microglial activation phenotypes on neurodegeneration and regeneration in Alzheimer's disease brain.In vivo positron emission tomographic imaging of glial responses to amyloid-beta and tau pathologies in mouse models of Alzheimer's disease and related disorders.Molecular imaging in Alzheimer's disease: new perspectives on biomarkers for early diagnosis and drug development.The Road Ahead to Cure Alzheimer's Disease: Development of Biological Markers and Neuroimaging Methods for Prevention Trials Across all Stages and Target Populations Microglial malfunction: the third rail in the development of Alzheimer's disease.An In Vivo (11)C-(R)-PK11195 PET and In Vitro Pathology Study of Microglia Activation in Creutzfeldt-Jakob Disease.Molecular Imaging of Neuroinflammation in Neurodegenerative Dementias: The Role of In Vivo PET Imaging Preventive immunization of aged and juvenile non-human primates to β-amyloid Molecular imaging of neuropsychiatric symptoms in Alzheimer's and Parkinson's disease.A phenotypic change but not proliferation underlies glial responses in Alzheimer disease Cardiovascular risk factors, cortisol, and amyloid-β deposition in Alzheimer's Disease Neuroimaging Initiative In vivo radioligand binding to translocator protein correlates with severity of Alzheimer's disease.Neuroimaging and other biomarkers for Alzheimer's disease: the changing landscape of early detection Microglia and inflammation in Alzheimer's disease.Microglia: key innate immune cells of the brain.Positron emission tomography imaging in neurological disorders.Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature.Imaging of microglia in patients with neurodegenerative disorders.Review: systemic inflammation and Alzheimer's disease.The translocator protein as a drug target in Alzheimer's disease.Mapping neuroinflammation in frontotemporal dementia with molecular PET imaging.In vivo PET imaging of neuroinflammation in Alzheimer's disease.Diagnostic function of the neuroinflammatory biomarker YKL-40 in Alzheimer's disease and other neurodegenerative diseases.(11)C-PBR28 binding to translocator protein increases with progression of Alzheimer's disease

P2860

Q26744219-7E7862A5-9188-491D-968C-72AECC9F3EE7 Q27691820-65314075-8A0D-4633-B793-461817234AE5 Q28393352-94721C32-3A99-4A35-A3E7-0C16C2133E18 Q30497749-C52B7EED-07A4-41A2-92C2-2FD1F825CF75 Q30542245-6C793B68-C689-4D8E-8680-B0328386CA49 Q33546364-0394C4E6-E629-4B64-9E6B-2DD94F84E096 Q33624586-5BA54673-EB47-4DEE-8E94-59F00DC99754 Q33664099-6BC46490-42A7-42F7-B287-B1A4351BC3AF Q33830110-F2C40C49-B1DB-49C4-BA4F-72B710A88037 Q33899600-21ECF94E-DD20-4FDF-8F6E-E41E46026AE8 Q33904501-AD9F6A5F-F47B-4DEC-8971-7493EA8A6693 Q34043074-E60851E5-471B-4878-89F6-E29EC6C251F6 Q34102331-1BA765F2-3A13-46B7-841F-895BE3988887 Q35158547-0E1C9942-E966-4C74-A793-ED0CC30512A9 Q35167904-8987C88B-1E2D-480B-A0C3-ADD5215A3DDB Q35504167-A5516D74-CFE5-4AB5-868A-E496B8B0EAA9 Q35599843-9AB5F56C-C0BA-403C-AC6E-BD2B9CB69F83 Q35654128-AF94DE4C-E397-4BD5-BEF5-68B0552C9952 Q35840623-07622965-F970-400B-B036-77FFC71F138F Q36165011-B1342B72-E982-48D0-9DFA-636FADA249A8 Q36348184-14EF595B-FB4C-4373-8DCD-F84FBC3E08A7 Q36358771-3F319D72-6540-4751-8E46-72692300DF0E Q36364053-CB88021B-02E6-4E64-A091-A420D2B86782 Q36391157-78C3DD09-6A8B-4830-A4A3-E21D0EFE6B2F Q36724965-431BB7A8-C280-47AE-8603-9D185569810D Q36888341-0E513869-7BDF-4EB7-B936-4B1870F7740D Q36889603-D43873FC-984E-489A-9C47-EB61A2AA76E5 Q36953874-4E594A0F-AD1E-4F6C-8E40-A163104AABFA Q37639158-119A38AB-32D1-48E4-9D3F-8CF68A2C7DD6 Q37703295-ABA891E8-CE82-4667-8049-4CAF891FA717 Q37809665-CEEC8D38-0585-4B1D-A807-027D8BF8346B Q37980609-8E5E47F2-2FD7-4252-9121-A99750E65201 Q37982377-FBB272A6-598F-4113-968A-1C7F9B2651F5 Q38015834-D0EEB546-6A8D-431F-9D47-CCB3F6595D67 Q38050498-CA1EAC46-248A-4A6B-9EA2-72B31E0BBD1E Q38195637-0A509B09-5FA9-4FD7-BA1D-F02ABE2D30BD Q38506602-F96A2222-9079-40DF-9BD8-6443ED1361A7 Q38779574-155428C3-F958-4AFD-8C71-AA49B9B714AE Q38915171-7833047B-9F20-46E8-A98B-554AA0140910 Q39137978-69495F06-94AC-46C1-9831-322D47AA53A8

P2860

Carbon 11-labeled Pittsburgh Compound B and carbon 11-labeled (R)-PK11195 positron emission tomographic imaging in Alzheimer disease.

http://www.wikidata.org/entity/Q37153379

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Carbon 11-labeled Pittsburgh C ...... imaging in Alzheimer disease.

@en

Carbon 11-labeled Pittsburgh Compound B and carbon 11-labeled

@nl

type

label

Carbon 11-labeled Pittsburgh C ...... imaging in Alzheimer disease.

@en

Carbon 11-labeled Pittsburgh Compound B and carbon 11-labeled

@nl

prefLabel

Carbon 11-labeled Pittsburgh C ...... imaging in Alzheimer disease.

@en

Carbon 11-labeled Pittsburgh Compound B and carbon 11-labeled

@nl

P1433

Q37153379-49338B40-54FB-4251-8532-319A9C639C25

P1476

Q37153379-AE5BCCD1-14AD-4572-9866-060E0AC94E58

P2093

Q37153379-63624CDF-33BE-49C5-BFAF-0948C0754868

Q37153379-6F1A9BD9-0CF9-4745-8F4F-52DFE42F3458

Q37153379-76D5A62C-1A59-4D54-A164-9F4B182EA584

Q37153379-B13DCD51-F010-427D-BA73-763A86BB8DE3

Q37153379-E89B02AF-94F0-49A6-AE21-2E2219A664C9

P2860

Q37153379-041F64EC-BB0B-4BF6-83FF-A674057C8D7E

Q37153379-09685076-82B9-49E7-B3EA-A7094A8902DD

Q37153379-1615E82B-9F3D-4C97-A829-EF37BE9FF758

Q37153379-1796A303-320B-480E-B1F7-CB82FC4FD40C

Q37153379-1D86F015-3149-4E02-915C-1748D253314C

Q37153379-218ED564-DA66-49A8-82E2-11FF8774D495

Q37153379-22D799ED-9CC2-4815-87BC-84CE33010441

Q37153379-32F2B08B-26ED-4F9C-AD61-F254F330214B

Q37153379-3488FD1A-0D47-43F5-889B-A8EDDB6115D6

Q37153379-395BB906-EBAD-4051-954A-666ABE8E0380

P304

Q37153379-66DF5F8F-FEC4-4126-9E2C-C0280FB1FAF1

P31

Q37153379-F5B5F6D8-2C5E-4AF5-8D49-FFDB87076CE0

P356

Q37153379-5E7C2CFD-2C5B-4115-A3D4-89DFE94973D1

P433

Q37153379-6BE91A3C-7CA3-42BE-A9B1-50BD998C7338

P478

Q37153379-CD7B104C-3CC8-40B9-9D76-4160A985E492

P50

Q37153379-D1C3C053-D00C-4F95-AAEF-8E974B56935F

Q37153379-F18DC594-C27D-4E6A-A042-C7A7E855E487

P577

Q37153379-C78024C2-8707-4747-B00F-57CEFC24F42C

P5875

Q37153379-39A2E36E-10E4-41ED-AA71-037EC964F273

P698

Q37153379-BA2F82A7-EBEF-4D61-AC8F-4E4EA9ED7633

P921

Q37153379-D02BB3FD-904D-45E6-9EB6-55CFF921465B

P932

Q37153379-DB0DD3FE-24A3-47C0-95A8-65B5EE2F5855

P356

ARCHNEUROL.2008.511

P1433

P1476

Carbon 11-labeled Pittsburgh C ...... c imaging in Alzheimer disease

@en

P2093

Brian J Lopresti

http://www.w3.org/2001/XMLSchema#string

Chester A Mathis

http://www.w3.org/2001/XMLSchema#string

Clayton A Wiley

http://www.w3.org/2001/XMLSchema#string

Julie Price

http://www.w3.org/2001/XMLSchema#string

Sriram Venneti

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Increased monoamine oxidase B activity in plaque-associated astrocytes of Alzheimer brains revealed by quantitative enzyme radioautography

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

Consensus nomenclature for in vivo imaging of reversibly binding radioligands.

Inflammatory processes in Alzheimer's disease.

Neurodegenerative disease and the neuroimmune axis (Alzheimer's and Parkinson's disease, and viral infections).

The high affinity peripheral benzodiazepine receptor ligand DAA1106 binds to activated and infected brain macrophages in areas of synaptic degeneration: implications for PET imaging of neuroinflammation in lentiviral encephalitis

The peripheral benzodiazepine receptor (Translocator protein 18kDa) in microglia: from pathology to imaging.

Frequent amyloid deposition without significant cognitive impairment among the elderly.

P304

60-67

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/ARCHNEUROL.2008.511

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

66

http://www.w3.org/2001/XMLSchema#string

P50

William E. Klunk

Steven T Dekosky

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23782537

http://www.w3.org/2001/XMLSchema#string

P698

19139300

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

2666881

http://www.w3.org/2001/XMLSchema#string